vimarsana.com
Home
Live Updates
BMS' Zeposia and AbbVie's Skyrizi Shake Up First-Line Prescr
BMS' Zeposia and AbbVie's Skyrizi Shake Up First-Line Prescr
BMS' Zeposia and AbbVie's Skyrizi Shake Up First-Line Prescribing Patterns in the US Ulcerative Colitis and Crohn's Disease Markets, Spherix Reports
/PRNewswire/ -- US gastroenterologists estimate that just under 60% of their ulcerative colitis (UC) and 55% of their Crohn's disease (CD) patients treated...
Related Keywords
Abbvie Humira ,
Abbvie Rinvoq ,
Abbvie Skyrizi ,
Janssen Stelara ,
Takeda Entyvio ,
Eli Lilly ,
Scott Upham ,
Pfizer ,
Linkedin ,
Twitter ,
Corporate Communications ,
Spherix Network ,
Global Insights ,
Realworld Dynamix ,
World Dynamix ,
Spherix Global Insights ,
Global Insights Contacts ,
Gastroenterology Franchise ,